SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-24-000029
Filing Date
2024-04-19
Accepted
2024-04-19 06:12:47
Documents
7
Period of Report
2024-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k_041924.htm 6-K 12635
2 EX-99.1 entyvio_approval.htm EX-99.1 21495
3 GRAPHIC entyvio_approval001.jpg GRAPHIC 288819
4 GRAPHIC entyvio_approval002.jpg GRAPHIC 288389
5 GRAPHIC entyvio_approval003.jpg GRAPHIC 242151
6 GRAPHIC entyvio_approval004.jpg GRAPHIC 284356
7 GRAPHIC entyvio_approval005.jpg GRAPHIC 228135
  Complete submission text file 0001395064-24-000029.txt   1870017
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 24855555
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)